
Ron Finklestien
Monday's ETF Movers: URA, TAN
In trading on Monday, the Uranium ETF is outperforming other ETFs, up about 3% on the day. Components of that ETF showing particular strength ...
Brokers Suggest Investing in NextEra (NEE): Read This Before Placing a Bet
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports ...
Dow Analyst Moves: AMZN
The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, ...
Goldman (GS) Plans to Expand Private Equity Credit Lines
The Goldman Sachs Group, Inc. GS plans to ramp up its lending services to private equity and asset managers, per Reuters. The bank also ...
Synopsys (SNPS) to Report Q2 Earnings: What's in the Offing?
Synopsys, Inc. SNPS is slated to report second-quarter fiscal 2024 results on May 22 after market close. The company anticipates revenues between $1.56 billion ...
Is Hims & Hers Health (HIMS) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports ...
Gilead (GILD) Announces Positive Interim Results on PBC Drug
Gilead Sciences, Inc. GILD announced positive interim results from the ongoing ASSURE study on pipeline candidate seladelpar. ASSURE is an open-label study evaluating the ...
MMV Stock: 7 Things to Know About MultiMetaVerse as Shares Rocket
Source: yusufdemirci / Shutterstock.com One of today’s biggest market movers is a little-known penny stock that is experiencing astronomical gains. MultiMetaVerse (NASDAQ:MMV) has surged ...












